|Day Low/High||17.85 / 18.24|
|52 Wk Low/High||15.56 / 18.95|
Here are Monday's top research calls, including upgrades for Blueprint Medicine, Gartner and Rockwell Collins and a downgrade for Boeing.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AM, BWP, CGNX, NYT, PME, TDC Downgrades: ARII, AXR, CECE, EVHC, FLY, HBM, HZN, MXC, PGTI, QADA, QADB, SMTX, STN Initiations: SGRY Read on to get TheStreet Quant Ratings' detailed report:
Boardwalk Pipeline (BWP) posted higher-than-anticipated earnings and revenue for the 2016 second quarter on Monday.
Trade-Ideas LLC identified Boardwalk Pipeline Partners (BWP) as a strong on high relative volume candidate
Operators in the Permian and Marcellus/Utica have the best prospects while those in the Haynesville, Barnett and Eagle Ford are the most challenged, CreditSights says in a report.
These 10 S&P 500 companies widely missed analysts' estimates, according to data from S&P Global Markets Intelligence. Were expectations too high?
Trade-Ideas LLC identified Boardwalk Pipeline Partners (BWP) as a weak on high relative volume candidate
Credit Suisse increased its price target on Boardwalk Pipeline Partners (BWP) stock and maintained its ‘outperform’ rating on Tuesday.